The seven‐gene signature risk score distributions, patient survival results and expression heatmap are shown in Figure 2C. SPARC, COL1A2 and FBN1 were differentially expressed in various TNM stages of GC (Figure 2D‐F). This evidence concerns the gene FBN1 and gastric cancer.